The ApoE peptide shared by ε2 and ε3 isoforms was also among those selected by RFE for discriminating AD cases and CN/BM- controls but the JMI algorithm selected a new peptide specific for ApoE ε4 for stratifying AsymAD cases. The gene discussed is APOE; the disease is Alzheimer disease.